| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0149-2918(96)80203-7 |
| P698 | PubMed publication ID | 8930449 |
| P2093 | author name string | Jonas MM | |
| P2860 | cites work | Interferon-associated retinopathy | Q70596182 |
| Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency | Q72590119 | ||
| Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis | Q72638615 | ||
| Factors predictive of the response to interferon in patients with chronic hepatitis C | Q72812587 | ||
| Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report | Q70313812 | ||
| Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production | Q70338857 | ||
| Alpha-interferon and reversible hypertriglyceridemia | Q70530151 | ||
| Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group | Q70542346 | ||
| The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study | Q70588149 | ||
| Polymerase chain reaction for the diagnosis of viral hepatitis B and C. | Q27472983 | ||
| Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis | Q27472985 | ||
| Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. | Q27472993 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
| Virus interference. I. The interferon | Q28181608 | ||
| Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis | Q29547897 | ||
| Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein | Q33584449 | ||
| Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection | Q33612002 | ||
| Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection | Q34058506 | ||
| Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. | Q34395519 | ||
| Descartes before the Horse: I Clone, Therefore I Am: The Hepatitis C Virus in Current Perspective | Q36422471 | ||
| Cardiotoxicity of interferon. A review of 44 cases | Q36626917 | ||
| Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis | Q37821429 | ||
| Side effects of alpha interferon | Q38745781 | ||
| Prevalence of Hepatitis C Viral Antibody in Transfused and Nontransfused Egyptian Children | Q39131187 | ||
| Regulation of cytokine gene expression | Q39603442 | ||
| Studies of the interferon receptors | Q40110926 | ||
| 2'5'Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells | Q40222557 | ||
| Human natural interferon-alpha producing cells | Q40724988 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. | Q41937839 | ||
| Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
| Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C. | Q42980716 | ||
| Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study | Q42980911 | ||
| Anti‐HCV immunoglobulin M antibody in patients with hepatitis C | Q42981418 | ||
| Cryptogenic chronic liver disease and hepatitis C virus infection in children | Q42981799 | ||
| Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma | Q42981939 | ||
| Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study | Q42981961 | ||
| Detection of hepatitis C virus RNA by nested polymerase chain reaction in sera of patients with chronic non-A, non-B hepatitis treated with interferon | Q42982490 | ||
| Anti-GOR and hepatitis C virus in autoimmune liver diseases | Q42982616 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis | Q42984295 | ||
| Transmission of hepatitis C virus by organ transplantation | Q42984341 | ||
| Maternal transfer of HCV. | Q42984668 | ||
| Hepatitis C: A sleeping giant? | Q42984709 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction | Q42984778 | ||
| Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay | Q42985310 | ||
| Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. | Q43035673 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. | Q43038973 | ||
| Hepatitis C virus infection in children with hemophilia: Characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction | Q43039194 | ||
| Changes in hepatitis C virus antigen in liver with antiviral therapy | Q43039294 | ||
| Histological findings in asymptomatic hepatitis C virus carriers | Q43039475 | ||
| Low prevalence of hepatitis C virus infection in patients with auto‐immune hepatitis type 1 | Q43039482 | ||
| Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. | Q43039574 | ||
| Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. | Q43041128 | ||
| Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C. | Q43041363 | ||
| Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment | Q43041553 | ||
| Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis | Q43048302 | ||
| Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses | Q43048465 | ||
| Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. | Q43048468 | ||
| Cryoglobulinemia with vasculitis associated with hepatitis C virus infection | Q43048486 | ||
| Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. | Q43048890 | ||
| Hepatitis C virus infection in spouses of patients with type C chronic liver disease. | Q43049232 | ||
| Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. | Q43049265 | ||
| Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus | Q43049410 | ||
| Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group | Q43049413 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| Interferon-induced chronic active hepatitis? | Q43466582 | ||
| Rheumatoid Arthritis-like Disease after Alpha-Interferon Therapy | Q43502828 | ||
| Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis | Q43610704 | ||
| Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda | Q43815439 | ||
| The prevalence of hepatitis C virus antibodies among hemodialysis patients | Q44136201 | ||
| Hepatitis C from a needlestick injury | Q44356693 | ||
| Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency | Q44849765 | ||
| Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection | Q45015808 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma | Q45844527 | ||
| Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis | Q45844531 | ||
| Hepatitis C virus antibodies among risk groups in Spain | Q45844599 | ||
| Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). | Q45852358 | ||
| Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity | Q45853607 | ||
| Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus | Q45867170 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis | Q45872909 | ||
| The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis | Q46858579 | ||
| Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process | Q52847990 | ||
| Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis. | Q54052083 | ||
| Interferon alfa and development of type 1 diabetes mellitus | Q54258023 | ||
| Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C | Q57236237 | ||
| Interferon for non-A, non-B chronic hepatitis | Q58803541 | ||
| Mother-to-infant transmission of hepatitis C virus | Q67486162 | ||
| Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha | Q67598999 | ||
| Alpha-Interferon Treatment of Chronic Hepatitis C: Need for Accurate Diagnosis in Selecting Patients | Q67716326 | ||
| Psoriasis induced by interferon-α | Q67780711 | ||
| Autoantibodies during alpha-interferon therapy for chronic hepatitis B | Q67970910 | ||
| Hepatitis C in hospital employees with needlestick injuries | Q67994147 | ||
| The pathology of hepatitis C | Q68079260 | ||
| Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa | Q68127333 | ||
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 110-125 | |
| P577 | publication date | 1996-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Clinical Therapeutics | Q15716601 |
| P1476 | title | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa | |
| P478 | volume | 18 Suppl B |
| Q37139282 | Hepatitis B and C in children | cites work | P2860 |
Search more.